Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point. Delahunt, B., Lamb, D. S., Srigley, J. R., Murray, J. D., Wilcox, C., Samaratunga, H., Atkinson, C., Spry, N. A., Joseph, D., & Denham, J. W. Pathology, 42:339–343, June, 2010.
Gleason scoring: a comparison of classical and modified (International Society of Urological Pathology) criteria using nadir PSA as a clinical end point [link]Paper  doi  bibtex   
@article{delahunt_gleason_2010,
	title = {Gleason scoring: a comparison of classical and modified ({International} {Society} of {Urological} {Pathology}) criteria using nadir {PSA} as a clinical end point},
	volume = {42},
	issn = {0031-3025},
	shorttitle = {Pathology},
	url = {http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=01268031-201042040-00006},
	doi = {10.3109/00313021003787924},
	urldate = {2011-11-02},
	journal = {Pathology},
	author = {Delahunt, Brett and Lamb, David S. and Srigley, John R. and Murray, Judy D. and Wilcox, Chantelle and Samaratunga, Hemamali and Atkinson, Christopher and Spry, Nigel A. and Joseph, David and Denham, James W.},
	month = jun,
	year = {2010},
	keywords = {Adenocarcinoma, Aged, Aged, 80 and over, Humans, Male, Middle Aged, Neoplasm Staging, Practice Guidelines as Topic, Prognosis, Prostate-Specific Antigen, Prostatic Neoplasms, ROC Curve},
	pages = {339--343},
}

Downloads: 0